News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
All Stories
News
CRISPR technology’s next wave: Eight companies to watch in 2024
June 20, 2024
Labiotech
Read Now
Press Release
CRISPR technology’s next wave: Eight companies to watch in 2024
June 20, 2024
Labiotech
Read Now
News
Top Five Privately Held Gene Editing Therapy Companies
May 31, 2024
Genetic Engineering & Biotechnology News
Read Now
Press Release
Top Five Privately Held Gene Editing Therapy Companies
May 31, 2024
Genetic Engineering & Biotechnology News
Read Now
News
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics
May 22, 2024
Ropes & Gray
Read Now
Press Release
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics
May 22, 2024
Ropes & Gray
Read Now
Press Release
Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
May 10, 2024
Read Now
Press Release
Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
May 10, 2024
Read Now
News
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
Press Release
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
Press Release
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
Read Now
Press Release
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
Read Now